A Study of BGM0504 Evaluating Weight Loss in Overweight or Obese Chinese Subjects

NCT06973681 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Overweight or Obesity

Interventions

DRUG: BGM0504
DRUG: BGM0504
DRUG: BGM0504
DRUG: Placebo

Sponsor

BrightGene Bio-Medical Technology Co., Ltd.